SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-18-000039
Filing Date
2018-03-13
Accepted
2018-03-13 16:14:03
Documents
5
Period of Report
2018-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-kpressrelease.htm 8-K 33850
2 EXHIBIT 99.1 exh991-earningsrelease.htm EX-99.1 171320
3 EXHIBIT 99.2 exh992bpx-501aml.htm EX-99.2 18494
4 bellicumlogo.jpg GRAPHIC 27677
5 qtr22017a03.jpg GRAPHIC 27677
  Complete submission text file 0001358403-18-000039.txt   301327
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 18686611
SIC: 2834 Pharmaceutical Preparations